Purpura, Thrombocytopaenic, Idiopathic (DBCOND0031053)
Identifiers
- Synonyms
- Not Available
Associated Data
- Indicated Drugs and Targets
- Not Available
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT00424177 Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT) treatment 2 completed NCT01440361 A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia. Not Available 2 withdrawn NCT00908037 Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP) treatment 2 completed NCT00102739 SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP) treatment 2 completed NCT00370331 RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag treatment 3 completed NCT01072162 Relative Bioavailibilty for Pediatric Powder for Suspension (PfOS) Formulation and Food Effect other 1 completed NCT00643929 LENS - Long-term Eltrombopag Observational Study Not Available Not Available completed NCT00688272 Study In Healthy Subjects To Evaluate The Photo-Irritant Potential Of Eltrombopag treatment 1 completed NCT00351468 EXTEND (Eltrombopag Extended Dosing Study) treatment 3 completed NCT01098487 A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) treatment 4 completed NCT01416311 Drug Use Investigation for REVOLADE (ITP) Not Available Not Available completed NCT00442871 Study Of SB-497115 in Healthy Subjects and Subjects With Mild, Moderate or Severe Renal Impairment treatment 1 completed NCT01064336 Promacta Pregnancy Registry Not Available Not Available completed NCT00359463 Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment treatment 1 completed